• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A pH-sensitive liposome formulation of a peptidomimetic-Dox conjugate for targeting HER2 + cancer.一种针对 HER2+癌症的肽模拟物-Dox 缀合物的 pH 敏感脂质体制剂。
Int J Pharm. 2022 Jan 25;612:121364. doi: 10.1016/j.ijpharm.2021.121364. Epub 2021 Dec 9.
2
Lyophilized liposomal formulation of a peptidomimetic-Dox conjugate for HER2 positive breast and lung cancer.用于 HER2 阳性乳腺癌和肺癌的肽模拟物-Dox 缀合物的冻干脂质体制剂。
Int J Pharm. 2023 May 25;639:122950. doi: 10.1016/j.ijpharm.2023.122950. Epub 2023 Apr 12.
3
Hyaluronic acid modified pH-sensitive liposomes for targeted intracellular delivery of doxorubicin.用于阿霉素靶向细胞内递送的透明质酸修饰的pH敏感脂质体
J Liposome Res. 2016 Dec;26(4):276-87. doi: 10.3109/08982104.2015.1117489. Epub 2016 Jan 19.
4
Estrogen-anchored pH-sensitive liposomes as nanomodule designed for site-specific delivery of doxorubicin in breast cancer therapy.基于雌激素锚定的 pH 敏感脂质体作为纳米模块,用于在乳腺癌治疗中实现阿霉素的靶向递送。
Mol Pharm. 2012 Jan 1;9(1):176-86. doi: 10.1021/mp200439z. Epub 2011 Nov 28.
5
Lipidated Peptidomimetic Ligand-Functionalized HER2 Targeted Liposome as Nano-Carrier Designed for Doxorubicin Delivery in Cancer Therapy.脂质化拟肽配体功能化的HER2靶向脂质体作为纳米载体用于癌症治疗中阿霉素的递送
Pharmaceuticals (Basel). 2021 Mar 6;14(3):221. doi: 10.3390/ph14030221.
6
A comparative study of folate receptor-targeted doxorubicin delivery systems: dosing regimens and therapeutic index.叶酸受体靶向阿霉素给药系统的比较研究:给药方案和治疗指数。
J Control Release. 2015 Jun 28;208:106-20. doi: 10.1016/j.jconrel.2015.04.009. Epub 2015 Apr 11.
7
A liposomal radionanoformulation for targeted drug delivery and real time monitoring by radionuclide imaging for HER2 overexpressing cancers.一种用于 HER2 过表达癌症的靶向药物递送和通过放射性核素成像进行实时监测的脂质体放射性纳米制剂。
Drug Dev Res. 2023 Nov;84(7):1553-1563. doi: 10.1002/ddr.22106. Epub 2023 Aug 14.
8
pH-Sensitive PEGylated Liposomal Silybin: Synthesis, In Vitro and In Vivo Anti-Tumor Evaluation.pH敏感的聚乙二醇化脂质体水飞蓟宾:合成、体外和体内抗肿瘤评价。
J Pharm Sci. 2021 Dec;110(12):3919-3928. doi: 10.1016/j.xphs.2021.08.015. Epub 2021 Aug 18.
9
Tumor targeting using anti-her2 immunoliposomes.使用抗HER2免疫脂质体进行肿瘤靶向
J Control Release. 2001 Jul 6;74(1-3):95-113. doi: 10.1016/s0168-3659(01)00315-7.
10
Integrin αβ-targeted liposomal drug delivery system for enhanced lung cancer therapy.整合素 αβ 靶向脂质体药物递送系统增强肺癌治疗。
Colloids Surf B Biointerfaces. 2021 May;201:111623. doi: 10.1016/j.colsurfb.2021.111623. Epub 2021 Feb 13.

引用本文的文献

1
Progress on liposome delivery systems in the treatment of bladder cancer.脂质体递送系统在膀胱癌治疗中的研究进展
RSC Adv. 2025 May 6;15(18):14315-14336. doi: 10.1039/d5ra00746a. eCollection 2025 Apr 28.
2
Innovations in Cancer Therapy: Endogenous Stimuli-Responsive Liposomes as Advanced Nanocarriers.癌症治疗的创新:内源性刺激响应脂质体作为先进的纳米载体
Pharmaceutics. 2025 Feb 13;17(2):245. doi: 10.3390/pharmaceutics17020245.
3
A comprehensive review on doxorubicin: mechanisms, toxicity, clinical trials, combination therapies and nanoformulations in breast cancer.关于阿霉素的全面综述:乳腺癌中的作用机制、毒性、临床试验、联合疗法及纳米制剂
Drug Deliv Transl Res. 2025 Jan;15(1):102-133. doi: 10.1007/s13346-024-01648-0. Epub 2024 Jun 17.
4
ULK1 Mediated Autophagy-Promoting Effects of Rutin-Loaded Chitosan Nanoparticles Contribute to the Activation of NF-κB Signaling Besides Inhibiting EMT in Hep3B Hepatoma Cells.芦丁载壳聚糖纳米粒通过 ULK1 介导的自噬促进作用激活 NF-κB 信号通路,抑制 Hep3B 肝癌细胞 EMT。
Int J Nanomedicine. 2024 May 18;19:4465-4493. doi: 10.2147/IJN.S443117. eCollection 2024.
5
Recent Preclinical and Clinical Progress in Liposomal Doxorubicin.脂质体阿霉素的近期临床前和临床进展
Pharmaceutics. 2023 Mar 9;15(3):893. doi: 10.3390/pharmaceutics15030893.
6
Neoadjuvant Gold Nanoshell-Based Photothermal Therapy Combined with Liposomal Doxorubicin in a Mouse Model of Colorectal Cancer.基于金纳米壳的新辅助光热治疗联合脂质体多柔比星在结直肠癌小鼠模型中的应用。
Int J Nanomedicine. 2023 Feb 17;18:829-841. doi: 10.2147/IJN.S389260. eCollection 2023.
7
Assessment of Antitumor and Antiproliferative Efficacy and Detection of Protein-Protein Interactions in Cancer Cells from 3D Tumor Spheroids.评估 3D 肿瘤球体中的肿瘤细胞的抗肿瘤和抗增殖功效及蛋白质-蛋白质相互作用的检测。
Curr Protoc. 2022 Oct;2(10):e569. doi: 10.1002/cpz1.569.

本文引用的文献

1
Lipidated Peptidomimetic Ligand-Functionalized HER2 Targeted Liposome as Nano-Carrier Designed for Doxorubicin Delivery in Cancer Therapy.脂质化拟肽配体功能化的HER2靶向脂质体作为纳米载体用于癌症治疗中阿霉素的递送
Pharmaceuticals (Basel). 2021 Mar 6;14(3):221. doi: 10.3390/ph14030221.
2
A grafted peptidomimetic for EGFR heterodimerization inhibition: Implications in NSCLC models.一种用于 EGFR 异二聚体抑制的嫁接肽拟肽:在 NSCLC 模型中的意义。
Eur J Med Chem. 2021 Apr 15;216:113312. doi: 10.1016/j.ejmech.2021.113312. Epub 2021 Feb 23.
3
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
4
Peptide-functionalized liposomes as therapeutic and diagnostic tools for cancer treatment.肽修饰的脂质体作为癌症治疗的治疗和诊断工具。
J Control Release. 2021 Jan 10;329:624-644. doi: 10.1016/j.jconrel.2020.09.055. Epub 2020 Oct 1.
5
Colorectal cancer statistics, 2020.2020 年结直肠癌统计数据。
CA Cancer J Clin. 2020 May;70(3):145-164. doi: 10.3322/caac.21601. Epub 2020 Mar 5.
6
Delivery of docetaxel using pH-sensitive liposomes based on D-α-tocopheryl poly(2-ethyl-2-oxazoline) succinate: Comparison with PEGylated liposomes.基于琥珀酸 D-α-生育酚聚(2-乙基-2-恶唑啉)的 pH 敏感脂质体递送多西他赛:与聚乙二醇化脂质体的比较。
Asian J Pharm Sci. 2019 Jul;14(4):391-404. doi: 10.1016/j.ajps.2018.07.005. Epub 2018 Sep 18.
7
HER2-targeted therapies - a role beyond breast cancer.曲妥珠单抗等 HER2 靶向治疗——超越乳腺癌的应用。
Nat Rev Clin Oncol. 2020 Jan;17(1):33-48. doi: 10.1038/s41571-019-0268-3. Epub 2019 Sep 23.
8
Dual-active targeting liposomes drug delivery system for bone metastatic breast cancer: Synthesis and biological evaluation.载双主动靶向配体脂质体药物传递系统用于治疗骨转移性乳腺癌:合成与生物学评价。
Chem Phys Lipids. 2019 Sep;223:104785. doi: 10.1016/j.chemphyslip.2019.104785. Epub 2019 Jun 11.
9
A dual pH-sensitive liposomal system with charge-reversal and NO generation for overcoming multidrug resistance in cancer.一种具有电荷反转和 NO 生成功能的双重 pH 敏感脂质体系统,用于克服癌症中的多药耐药性。
Nanoscale. 2019 Mar 7;11(9):3814-3826. doi: 10.1039/c8nr06218h. Epub 2019 Jan 2.
10
Dual Functionalized 5-Fluorouracil Liposomes as Highly Efficient Nanomedicine for Glioblastoma Treatment as Assessed in an In Vitro Brain Tumor Model.双重功能化 5-氟尿嘧啶脂质体作为高效的神经胶质瘤治疗纳米药物在体外脑肿瘤模型中的评估。
J Pharm Sci. 2018 Nov;107(11):2902-2913. doi: 10.1016/j.xphs.2018.07.020. Epub 2018 Jul 25.

一种针对 HER2+癌症的肽模拟物-Dox 缀合物的 pH 敏感脂质体制剂。

A pH-sensitive liposome formulation of a peptidomimetic-Dox conjugate for targeting HER2 + cancer.

机构信息

School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana at Monroe, Monroe, LA 71201, USA.

Department of Pathology, Louisiana State University Health Sciences Center, 1501 Kings Hwy, Shreveport, LA 71103, USA.

出版信息

Int J Pharm. 2022 Jan 25;612:121364. doi: 10.1016/j.ijpharm.2021.121364. Epub 2021 Dec 9.

DOI:10.1016/j.ijpharm.2021.121364
PMID:34896567
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8751737/
Abstract

Cancer treatment faces the challenge of selective delivery of the cytotoxic drug to the desired site of action to minimize undesired side effects. The liposomal formulation containing targeting ligand conjugated cytotoxic drug can be an effective approach to specifically deliver chemotherapeutic drugs to cancer cells that overexpress a particular cell surface receptor. This research focuses on the in vitro and in vivo studies of a peptidomimetic ligand attached doxorubicin for the HER2 positive lung and breast cancer cells transported by a pH-dependent liposomal formulation system for the enhancement of targeted anticancer treatment. The selected pH-sensitive liposome formulation showed effective pH-dependent delivery of peptidomimetic-doxorubicin conjugate at lower pH conditions mimicking tumor microenvironment (pH-6.5) compared to normal physiological conditions (pH 7.4), leading to the improvement of cell uptake. In vivo results revealed the site-specific delivery of the formulation and enhanced antitumor activity with reduced toxicity compared to the free doxorubicin (Free Dox). The results suggested that the targeting ligand conjugated cytotoxic drug with the pH-sensitive liposomal formulation is a promising approach to chemotherapy.

摘要

癌症治疗面临的挑战是将细胞毒性药物选择性地递送到所需的作用部位,以最小化不良反应。含有靶向配体连接的细胞毒性药物的脂质体制剂可以是一种将化疗药物特异性递送到过表达特定细胞表面受体的癌细胞的有效方法。这项研究集中于通过 pH 依赖性脂质体制剂系统对 HER2 阳性肺癌和乳腺癌细胞进行转导的肽模拟配体连接阿霉素的体外和体内研究,以增强靶向抗癌治疗。与正常生理条件(pH7.4)相比,所选 pH 敏感脂质体制剂在模拟肿瘤微环境(pH6.5)的较低 pH 条件下显示出肽模拟物-阿霉素缀合物的有效 pH 依赖性递药,从而提高了细胞摄取。体内结果表明,与游离阿霉素(Free Dox)相比,该制剂具有更好的肿瘤靶向性和抗肿瘤活性,同时降低了毒性。结果表明,靶向配体连接的细胞毒性药物与 pH 敏感脂质体制剂是一种有前途的化疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8a9/8751737/90c14ccf956d/nihms-1765032-f0013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8a9/8751737/434f11f7cc4b/nihms-1765032-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8a9/8751737/8fd5f8301682/nihms-1765032-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8a9/8751737/16bbafb8c7bb/nihms-1765032-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8a9/8751737/f25624a0be36/nihms-1765032-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8a9/8751737/50a06ec814f7/nihms-1765032-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8a9/8751737/cc64ab03f7c1/nihms-1765032-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8a9/8751737/fce4cc420d12/nihms-1765032-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8a9/8751737/65159543d715/nihms-1765032-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8a9/8751737/2db5ffe94bd3/nihms-1765032-f0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8a9/8751737/70a2ea6a0f86/nihms-1765032-f0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8a9/8751737/4f608fecbc6a/nihms-1765032-f0012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8a9/8751737/90c14ccf956d/nihms-1765032-f0013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8a9/8751737/434f11f7cc4b/nihms-1765032-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8a9/8751737/8fd5f8301682/nihms-1765032-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8a9/8751737/16bbafb8c7bb/nihms-1765032-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8a9/8751737/f25624a0be36/nihms-1765032-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8a9/8751737/50a06ec814f7/nihms-1765032-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8a9/8751737/cc64ab03f7c1/nihms-1765032-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8a9/8751737/fce4cc420d12/nihms-1765032-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8a9/8751737/65159543d715/nihms-1765032-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8a9/8751737/2db5ffe94bd3/nihms-1765032-f0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8a9/8751737/70a2ea6a0f86/nihms-1765032-f0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8a9/8751737/4f608fecbc6a/nihms-1765032-f0012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8a9/8751737/90c14ccf956d/nihms-1765032-f0013.jpg